Quinolone antibiotics induce Shiga toxin-encoding bacteriophages, toxin production, and death in mice

Journal of Infectious Diseases

Volumn 181, Issue 2, 2000, Pages 664-670

  Zhang, Xiaoping ^a,b   McDaniel, Aaron D ^a,c   Wolf, Lucas E ^a,d   Keusch, Gerald T ^a   Waldor, Matthew K ^a   Acheson, David W K ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b RUTGERS UNIVERSITY   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d Department of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIPROFLOXACIN; FOSFOMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SHIGA TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL VIRULENCE; BACTERIOPHAGE; CONTROLLED STUDY; ESCHERICHIA COLI O157; GRAM NEGATIVE INFECTION; LETHALITY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TOXIN SYNTHESIS;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS; BACTERIAL TOXINS; CIPROFLOXACIN; COLIPHAGES; DISEASE MODELS, ANIMAL; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; FOSFOMYCIN; HUMANS; INTESTINES; MALE; MICE; SHIGA TOXINS;

EID: 0034056335     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315239     Document Type: Article

References (33)

1. Acheson DWK, Keusch GT. Which Shiga toxin producing E. coli are important? ASM News 1996; 62:302-6.
2. Kaper JB, O'Brien AD. Escherichia coli O157:H7 and other Shiga toxin producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998.
3. Griffin PM. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli. In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, eds. Infections of the gastrointestinal tract. New York: Raven Press, 1995:739-61.
4. O'Brien AD, Newland JW, Miller SF, Holmes RK, Williams-Smith H, Formal SB. Shiga-like toxin converting phages from Escherichia coli strains that cause hemorrhagic colitis or infantile diarrhea. Science 1984; 226:694-6.
5. Huang A, Frieman J, Brunton JL. Characterization of a bacteriophage that carries the genes for production of Shiga-like toxin 1 in Escherichia coli. J Bacteriol 1987; 169:4308-12.
6. Neely MN, Friedman DI. Functional and genetic analysis of regulatory regions of coliphage H-19B: location of Shiga-like toxin and lysis genes suggest a role for phage functions in toxin release. Mol Microbiol 1998; 28:1255-67.
7. Muhldorfer I, Hacker J, Keusch GT, et al. Regulation of the Shiga-like toxin II operon in Escherichia coli. Infect Immun 1996; 64:495-502.
8. Acheson DWK, Donohue-Rolfe A. Cancer-associated hemolytic uremic syndrome: a possible role of mitomycin C in relation to Shiga-like toxins. J Clin Oncol 1989; 7:1943.
9. Karch H, Goroncy-Bermes H, Opferkuch W, Droll HP, O'Brien AD. Subinhibitory concentrations of antibiotics modulate amount of Shiga-like toxin produced by Escherichia coli. In: Adam D, Hahr H, Opterkuch W, eds. The influence of antibiotics on the host-parasite relationship. Berlin: Springer Verlag, 1985:239-45.
10. Walterspiel JN, Ashkenazi S, Morrow AL, Cleary TG. Effect of subinhibitory concentrations of antibiotics on extracellular Shiga-like toxin 1. Infection 1992; 20:25-9.
11. Matsushiro A, Sato K, Miyamoto H, Yamamura T, Honda T. Induction of prophages of enterohemorrhagic Escherichia coli O157:H7 with norfloxacin. J Bacteriol 1999; 181:2257-60.
12. Pavia AT, Nichols CR, Green DP, et al. Hemolytic-uremic syndrome during an outbreak of Escherichia coli O157:H7 infections in institutions for mentally retarded persons: clinical and epidemiological observations. J Pediatr 1990; 116:544-51.
13. Takeda T, Yoshino YY, Uchida H, Ikeda N, Tanimura M. Early use of fosfomycin for Shiga toxin-producing Escherichia coli O157:H7 infection reduces the risk of hemolytic-uremic syndrome. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998:385-7.
14. Moxley RA, Francis DH. Overview of animal models. In: Kaper JB, O'Brien AD, eds. Escherichia coli O157:H7 and other Shiga toxin producing E. coli strains. Washington, DC: American Society for Microbiology Press, 1998:249-60.
15. Wadolkowski EA, Burris JA, O'Brien AD. Mouse model for colonization and disease caused by enterohemorrhagic Escherichia coli O157:H7. Infect Immun 1990; 58:2438-45.
16. Karpman D, Connell H, Svensson M. The role of lipopolysaccharide and Shiga-like toxin in a mouse model of Escherichia coli O157:H7 infection. J Infect Dis 1997; 175:611-20.
17. Kurioka T, Yunou Y, Kita E. Enhancement of susceptibility to Shiga toxin-producing Escherichia coli O157:H7 by protein calorie malnutrition in mice. Infect Immun 1998; 66:1726-34.
18. Wadolkowski EA, Sung LM, Burris JA, Samuel JE, O'Brien AD. Acute renal tubular necrosis and death of mice orally infected with Escherichia coli strains that produce Shiga-like toxin type II. Infect Immun 1990; 58:3959-65.
19. Acheson DWK, Reidl J, Zhang X, Keusch GT, Mekalanos JJ, Waldor MK. In vivo transduction with Shiga toxin 1-encoding phage. Infect Immun 1998; 66:4496-8.
20. Acheson DWK, Frankson K, Willis D, and the STEC Prevalence Study Group. Multicenter prevalence study of Shiga toxin producing Escherichia coli [abstract C-205]. In: Proceedings of the 98th general meeting of the American Society for Microbiology. Washington, DC: American Society for Microbiology, 1998.
21. Tesh VL, O'Brien AD. The pathogenic mechanisms of Shiga toxin and the Shiga-like toxins. Mol Microbiol 1991; 5:1817-22.
22. Schmidt H, Scheef J, Janetzki-Mittmann C, Datz M, Karch H. An ile X tRNA gene is located close to the Shiga toxin II operon in enterohemorrhagic Escherichia coli O157 and non-O157 strains. FEMS Microbiol Lett 1997; 149:39-44.
23. Sung LM, Jackson MP, O'Brien AD, Holmes RK. Transcription of the Shiga-like toxin type II and Shiga-like toxin type II variant operons of Escherichia coli. J Bacteriol 1990; 172:6386-95.
24. Donnenberg MS, Kaper JB. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vector. Infect Immun 1991; 59:4310-7.
25. Jacewicz M, Feldman HA, Donohue-Rolfe A, Balasubramanian KA, Keusch GT. Pathogenesis of Shigella diarrhea. XIV. Analysis of Shiga toxin receptors on cloned Hela cells. J Infect Dis 1989; 159:881-9.
26. Donohue-Rolfe A, Acheson DWK, Kane AV, Keusch GT. Purification of Shiga toxin and Shiga-like toxins I and II by receptor analog affinity chromatography with immobilized P1 glycoprotein and production of cross-reactive monoclonal antibodies. Infect Immun 1989; 57:3888-93.
27. Calderwood SB, Mekalanos JJ. Iron regulation of Shiga-like toxin expression in Escherichia coli is mediated by the fur locus. J Bacteriol 1987; 169:4759-64.
28. Carter AO, Borczyk AA, Carlson JAK, et al. A severe outbreak of Escherichia coli O157:H7-associated hemorrhagic colitis in a nursing home. N Engl J Med 1987; 317:1496-500.
29. Karch H, Strockbine NA, O'Brien AD. Growth of Escherichia coli in the presence of trimethoprim-sulfamethoxazole facilitates detection of Shiga-like toxin producing strains by colony blot assay. FEMS Microbiol Lett 1986; 35:141-5.
30. Waldor M. Bacteriophage biology and bacterial virulence. Trends Microbiol 1998; 6:295-7.
31. Kehl KS, Havens P, Behnke CE, Acheson DWK. Evaluation of the Premier EHEC assay for detection of Shiga toxin producing Escherichia coli. J Clin Microbiol 1997; 35:2051-4.
32. Tschape H, Prager R, Streckel W, Fruth A, Tietze E, Bohme G. Verotoxinogenic Citrobacter freundii associated with severe gastroenteritis and cases of haemolytic uraemic syndrome in a nursery school: green butter as the infection source. Epidemiol Infect 1995; 114:441-50.
33. Paton AW, Paton JC. Enterobacter cloacae producing a Shiga-like toxin II related cytotoxin associated with a case of hemolytic-uremic syndrome. J Clin Microbiol 1996; 34:463-5.